BCAX Bicara Therapeutics Inc. - Common Stock
$20,42
Cena · Maj 20, 2026
Dane fundamentalne na dzień Maj 11, 2026
Zakres 52 tyg.
$8–$24
77% of range
Ocena Analityków
BUY
20 analysts
Cena Docelowa
$31
+54% upside
P/E (TTM)
-6.7
ROE
-33.0%
Marża Zysku Netto
—
BCAX Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$20.42
Kapitalizacja Rynkowa
$953M
P/E (TTM)
-6.7
EPS (TTM)
$-2.52
Przychody (TTM)
—
Stopa dywidendy
—
ROE
-33.0%
D/E Dług/Kapitał
—
Zakres 52 tyg.
$8 – $24
BCAX Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
—
EPS
$-2.52
2023-12-31
→
2025-12-31
Wolny przepływ pieniężny
$-107M
2024-12-31
→
2025-12-31
Marże
—
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
BCAX
Mediana porównawcza
P/E (TTM)
-6.7
—
P/B
2.4
7.4
Price / FCF (Cena / FCF)
-8.9
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
BCAX
Mediana porównawcza
ROA
-29.3%
-47.6%
ROE
-33.0%
-62.8%
ROIC
-38.8%
—
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
BCAX
Mediana porównawcza
Current Ratio (Wskaźnik bieżący)
14.6
5.6
Quick Ratio (Wskaźnik Szybkości)
14.3
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
BCAX
Mediana porównawcza
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
BCAX
Mediana porównawcza
BCAX Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
20 analityków
- Mocne kupno 6 30,0%
- Kup 10 50,0%
- Trzymaj 4 20,0%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
13 analityków · 2026-05-20
Mediana
$31.00
Teraz
$20.42
Niski
$16.00
Wysoki
$46.00
Średni cel
$31.00
+51,8%
Średnia cel
$31.46
+54,1%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
-0.08%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 31 marca 2026 | $-0.93 | $-0.77 | -0.16% |
| 31 grudnia 2025 | $-0.68 | $-0.68 | 0.00% |
| 30 września 2025 | $-0.67 | $-0.56 | -0.11% |
| 30 czerwca 2025 | $-0.50 | $-0.58 | 0.08% |
| 31 marca 2025 | $-0.68 | $-0.42 | -0.26% |
| 31 grudnia 2024 | $-0.39 | $-0.33 | -0.06% |
Porównanie jednostek Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| BCAX | $953M | -6.7 | — | — | -33.0% | — |
| PGEN | $1.48B | -3.1 | 146.7% | -2588.2% | 3159.1% | — |
| DMRA | — | — | 38.3% | -17981.1% | -167.0% | — |
| VIR | $841M | -1.9 | -7.6% | -638.9% | -51.1% | — |
| KALV | $685M | -3.7 | — | — | -172.9% | — |
| BHVN | $1.50B | -1.6 | — | — | -310.8% | — |
| AVBP | $854M | -4.7 | — | — | -59.7% | — |
| OLMA | $2.03B | -13.4 | — | — | -39.4% | — |
| MPLT | $773M | -0.9 | — | — | -151.1% | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 14
| Wskaźnik | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| R&D Expense | · | $64M | $31M | |
| SG&A Expense | $31M | $19M | $9M | |
| Operating Expenses | $156M | $82M | $40M | |
| Operating Income | $-156M | $-82M | $-40M | |
| Interest Income | $18M | $15M | $1M | |
| Other Non-op | $18M | $15M | $-12M | |
| Pretax Income | $-138M | $-68M | $-52M | |
| Income Tax | $217.0K | $187.0K | $5.0K | |
| Net Income | $-138M | $-68M | $-52M | |
| EPS (Basic) | $-2.52 | $-4.05 | $-89.61 | |
| EPS (Diluted) | $-2.52 | $-4.05 | $-89.61 | |
| Shares (Basic) | 54,676,896,000 | 16,805,524,000 | 580,109,000 | |
| Shares (Diluted) | 54,676,896,000 | 16,805,524,000 | 580,109,000 | |
| EBITDA | $-156M | $-82M | · |
Bilans 19
| Wskaźnik | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $97M | $490M | $230M | |
| Short-term Investments | $318M | $0 | · | |
| Prepaid Expense | $7M | $13M | $633.0K | |
| Current Assets | $422M | $503M | $231M | |
| PP&E (Net) | $330.0K | $155.0K | $202.0K | |
| Other Non-current Assets | $7M | $7M | $2M | |
| Total Assets | $431M | $510M | $234M | |
| Accrued Liabilities | · | $13M | $8M | |
| Current Liabilities | $29M | $18M | $15M | |
| Capital Leases | $593.0K | $131.0K | $372.0K | |
| Other Non-current Liabilities | · | $0 | $17.0K | |
| Total Liabilities | $30M | $18M | $15M | |
| Common Stock | $7.0K | $7.0K | $2.0K | |
| Paid-in Capital | $760M | $713M | $4M | |
| Retained Earnings | $-359M | $-221M | $-153M | |
| AOCI | $243.0K | $0 | · | |
| Stockholders' Equity | $401M | $492M | $-149M | |
| Liabilities + Equity | $431M | $510M | $234M | |
| Shares Outstanding | 56,600,724 | 54,440,013 | 640,386 |
Przepływy pieniężne 10
| Wskaźnik | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Stock-based Comp | $15M | $7M | $2M | |
| Deferred Tax | $0 | $0 | $0 | |
| Operating Cash Flow | $-107M | $-75M | $-46M | |
| CapEx | $280.0K | $71.0K | $586.0K | |
| Investing Cash Flow | $-318M | $-9.0K | $-586.0K | |
| Stock Issued | $29M | $332M | $0 | |
| Net Stock Activity | $29M | $332M | · | |
| Financing Cash Flow | $32M | $334M | $272M | |
| Net Change in Cash | $-393M | $259M | $226M | |
| Free Cash Flow | $-107M | $-75M | · |
Rentowność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| ROA | -29.3% | -18.3% | · | |
| ROE | -33.0% | -13.6% | · | |
| ROIC | -38.8% | -16.8% | · |
Płynność i wypłacalność 2
| Wskaźnik | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 14.6 | 27.9 | · | |
| Quick Ratio | 14.3 | 27.2 | · |
Wycena (TTM) 8
| Wskaźnik | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Net Income TTM | $-138M | $-68M | · | |
| Market Cap | $953M | $948M | · | |
| P/E | -6.7 | -4.3 | · | |
| P/B | 2.4 | 1.9 | · | |
| P / Tangible Book | 2.4 | 1.9 | · | |
| P / Cash Flow | -8.9 | -12.7 | · | |
| P / FCF | -8.9 | -12.7 | · | |
| Earnings Yield | -15.0% | -23.2% | · |
Rachunek zysków i strat 14
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | · | · | $33M | $25M | $34M | · | $16M | $16M | $12M | $10M | |
| SG&A Expense | $13M | $8M | $8M | $7M | $7M | $7M | $5M | $4M | $3M | $3M | |
| Operating Expenses | $60M | $41M | $41M | $32M | $42M | $27M | $21M | $20M | $15M | $14M | |
| Operating Income | $-60M | $-41M | $-41M | $-32M | $-42M | $-27M | $-21M | $-20M | $-15M | $-14M | |
| Interest Income | $4M | $4M | $4M | $5M | $5M | $6M | $3M | $3M | $3M | $1M | |
| Other Non-op | $4M | $4M | $4M | $5M | $5M | $6M | $3M | $3M | $3M | $1M | |
| Pretax Income | $-56M | $-37M | $-36M | $-27M | $-37M | $-21M | $-17M | $-17M | $-13M | $-12M | |
| Income Tax | $52.0K | $53.0K | $40.0K | $52.0K | $72.0K | $186.0K | $0 | $0 | $1.0K | $5.0K | |
| Net Income | $-56M | $-37M | $-36M | $-27M | $-37M | $-21M | $-17M | $-17M | $-13M | $-12M | |
| EPS (Basic) | $-0.93 | $-0.67 | $-0.67 | $-0.50 | $-0.68 | $35.50 | $-1.60 | $-19.01 | $-18.94 | $-19.43 | |
| EPS (Diluted) | $-0.93 | $-0.67 | $-0.67 | $-0.50 | $-0.68 | $35.50 | $-1.60 | $-19.01 | $-18.94 | $-19.43 | |
| Shares (Basic) | 60,717,041 | 54,513,336,391 | 54,563,864 | 54,539,230 | 54,456,515 | 16,793,065,830 | 10,901,138 | 896,744 | 660,288 | 579,545,517 | |
| Shares (Diluted) | 60,717,041 | 54,513,336,391 | 54,563,864 | 54,539,230 | 54,456,515 | 16,793,065,830 | 10,901,138 | 896,744 | 660,288 | 579,545,517 | |
| EBITDA | $-60M | · | $-41M | $-32M | $-42M | · | $-21M | · | · | · |
Bilans 19
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $323M | $97M | $172M | $437M | $462M | $490M | $521M | · | · | $230M | |
| Short-term Investments | $216M | $318M | $118M | · | · | $0 | · | · | · | · | |
| Prepaid Expense | $5M | $7M | $7M | $8M | $9M | $13M | $756.0K | · | · | $633.0K | |
| Current Assets | $545M | $422M | $297M | $444M | $471M | $503M | $522M | · | · | $231M | |
| PP&E (Net) | $346.0K | $330.0K | $135.0K | $117.0K | $136.0K | $155.0K | $130.0K | · | · | $202.0K | |
| Other Non-current Assets | $7M | $7M | $8M | $7M | $7M | $7M | $2M | · | · | $2M | |
| Total Assets | $554M | $431M | $425M | $454M | $478M | $510M | $524M | · | · | $234M | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | $8M | |
| Current Liabilities | $39M | $29M | $21M | $17M | $19M | $18M | $14M | · | · | $15M | |
| Capital Leases | $301.0K | $593.0K | $880.0K | $1M | $0 | $131.0K | $137.0K | · | · | $372.0K | |
| Other Non-current Liabilities | · | · | · | · | · | · | $0 | · | · | $17.0K | |
| Total Liabilities | $40M | $30M | $22M | $18M | $19M | $18M | $15M | · | · | $15M | |
| Common Stock | $8.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | · | · | $2.0K | |
| Paid-in Capital | $929M | $760M | $724M | $720M | $717M | $713M | $710M | · | · | $4M | |
| Retained Earnings | $-415M | $-359M | $-322M | $-285M | $-258M | $-221M | $-200M | · | · | $-153M | |
| AOCI | $-243.0K | $243.0K | $-136.0K | · | · | $0 | · | · | · | · | |
| Stockholders' Equity | $514M | $401M | $403M | $435M | $459M | $492M | $510M | · | · | $-149M | |
| Liabilities + Equity | $554M | $431M | $425M | $454M | $478M | $510M | $524M | · | · | $234M | |
| Shares Outstanding | 65,547,037 | 56,600,724 | 54,612,477 | 54,556,078 | 54,528,975 | 54,440,013 | 54,409,708 | · | · | 640,386 |
Przepływy pieniężne 9
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $6M | $4M | $4M | $3M | $3M | $3M | $2M | $1M | $1M | $765.0K | |
| Operating Cash Flow | $-38M | $-24M | $-29M | $-26M | $-28M | $-30M | $-17M | $-13M | $-15M | $-8M | |
| CapEx | $60.0K | $238.0K | $42.0K | $0 | $0 | $40.0K | $8.0K | $19.0K | $4.0K | $436.0K | |
| Investing Cash Flow | $101M | $-82M | $-236M | $0 | $0 | $-40.0K | $-8.0K | $-19.0K | $58.0K | $-436.0K | |
| Stock Issued | $162M | $29M | · | · | $0 | $-1M | · | · | · | $0 | |
| Net Stock Activity | $162M | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $163M | $31M | $436.0K | $135.0K | $460.0K | $-975.0K | $334M | $734.0K | $137.0K | $195M | |
| Net Change in Cash | $227M | $-75M | $-265M | $-25M | $-28M | $-31M | $317M | $-12M | $-14M | $186M | |
| Free Cash Flow | $-38M | · | · | · | $-28M | · | · | · | · | · |
Rentowność 3
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -10.9% | · | -7.7% | -12.1% | -15.4% | · | -6.7% | · | · | · | |
| ROE | -11.6% | · | -8.0% | -12.6% | -16.1% | · | -6.9% | · | · | · | |
| ROIC | -11.7% | · | -10.1% | -7.4% | -9.1% | · | -4.0% | · | · | · |
Płynność i wypłacalność 2
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 13.9 | · | 14.1 | 25.8 | 24.6 | · | 36.0 | · | · | · | |
| Quick Ratio | 13.7 | · | 13.8 | 25.3 | 24.2 | · | 36.0 | · | · | · |
Wycena (TTM) 8
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-157M | · | $-118M | $-99M | $-84M | · | $-70M | · | · | · | |
| Market Cap | $1.30B | · | $862M | $507M | $711M | · | $1.39B | · | · | · | |
| P/E | -7.2 | · | -4.6 | -0.4 | -0.3 | · | -0.3 | · | · | · | |
| P/B | 2.5 | · | 2.1 | 1.2 | 1.5 | · | 2.7 | · | · | · | |
| P / Tangible Book | 2.5 | · | 2.1 | 1.2 | 1.5 | · | 2.7 | · | · | · | |
| P / Cash Flow | -34.8 | · | · | · | -25.3 | · | · | · | · | · | |
| P / FCF | -34.7 | · | · | · | -25.3 | · | · | · | · | · | |
| Earnings Yield | -14.0% | · | -21.9% | -234.5% | -308.8% | · | -305.4% | · | · | · |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Zysk netto | $-138M | $-68M | $-52M |
| Rozwodniony EPS | $-2.52 | $-4.05 | $-89.61 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Wskaźnik bieżący | 14.6 | 27.9 | — |
| Wskaźnik Szybkości | 14.3 | 27.2 | — |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Wolny przepływ pieniężny | $-107M | $-75M | — |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.